<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02909517</url>
  </required_header>
  <id_info>
    <org_study_id>14-416</org_study_id>
    <nct_id>NCT02909517</nct_id>
  </id_info>
  <brief_title>The Role of Inflammation in Ocular Tumours</brief_title>
  <official_title>The Role of Inflammation in Ocular Tumours</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Unity Health Toronto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Unity Health Toronto</source>
  <brief_summary>
    <textblock>
      This prospective, non-therapeutic study will determine whether a novel imaging technique can&#xD;
      identify presumptive tumour associated macrophages (TAMs) in patients with ocular tumours.&#xD;
&#xD;
      The investigators will evaluate 5 groups:&#xD;
&#xD;
        1. Choroidal nevus&#xD;
&#xD;
        2. Choroidal indeterminate melanocytic lesion&#xD;
&#xD;
        3. Choroidal melanoma&#xD;
&#xD;
        4. Suspected metastatic tumour (ie, primary tumour elsewhere)&#xD;
&#xD;
        5. Locally treated ocular tumours&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2016</start_date>
  <completion_date type="Anticipated">May 2020</completion_date>
  <primary_completion_date type="Anticipated">May 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Identification of macrophages</measure>
    <time_frame>1 week</time_frame>
  </primary_outcome>
  <number_of_groups>5</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Ocular Melanoma</condition>
  <arm_group>
    <arm_group_label>Choroidal nevus</arm_group_label>
    <description>Requires distinction from melanoma through diagnostic testing (low-risk features)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Choroidal indeterminate melanocytic lesion</arm_group_label>
    <description>Requires diagnostic testing for identification and distinction from nevus and melanoma (high-risk features)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Choroidal melanoma</arm_group_label>
    <description>Requires confirmation of diagnosis and evaluation for potential metatstases</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Suspected metastatic tumour</arm_group_label>
    <description>Requires identification of primary tumour (ie, primary tumour elsewhere)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Locally treated ocular tumour</arm_group_label>
    <description>Requires followup to evaluate response to treatment and potential change or repeat therapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>cSLO imaging</intervention_name>
    <arm_group_label>Choroidal indeterminate melanocytic lesion</arm_group_label>
    <arm_group_label>Choroidal melanoma</arm_group_label>
    <arm_group_label>Choroidal nevus</arm_group_label>
    <arm_group_label>Locally treated ocular tumour</arm_group_label>
    <arm_group_label>Suspected metastatic tumour</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Potential study subjects will be identified from within the circle of care of the attending&#xD;
        physicians. Subjects must be 18 years of age or older, be able to understand the study&#xD;
        protocol, and provide informed consent. They must be able to attend all three visits&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Any tentative clinical diagnosis of:&#xD;
&#xD;
          1. Choroidal nevus (low-risk features):&#xD;
&#xD;
          2. Choroidal indeterminate melanocytic lesion (high-risk features)&#xD;
&#xD;
          3. Choroidal melanoma&#xD;
&#xD;
          4. Suspected metastatic tumour (ie, primary tumour elsewhere)&#xD;
&#xD;
          5. Locally treated ocular tumours&#xD;
&#xD;
        Note that a patient can enroll in this study twice, once before treatment and once after,&#xD;
        provided that at least one month has passed since initiation of treatment. This patient&#xD;
        will count twice (ie, once in each of two study arms)&#xD;
&#xD;
        Male and female age 18 years and older Ability to provide informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Allergy to angiography dye&#xD;
&#xD;
          -  Cases that do not meet the above criteria for tumor size will be ineligible to&#xD;
             participate in the study.&#xD;
&#xD;
          -  Patients not able to provide consent for the study.&#xD;
&#xD;
          -  Patients with a poor view of the fundus due to cataract or vitreous hemorrhage.&#xD;
&#xD;
          -  Patients &lt; 18 years of age. Any concurrent unrelated eye diagnosis&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shelley Boyd, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Unity Health Toronto</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Emily Mathieu, PhD</last_name>
    <phone>4168646060</phone>
    <phone_ext>2893</phone_ext>
    <email>mathieue@smh.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>St Michael's Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5B 1W8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shelley Boyd, MD</last_name>
      <phone>416-864-6060</phone>
      <phone_ext>2893</phone_ext>
      <email>BoydS@smh.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Princess Margaret Cancer Centre, Ontario</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 2M9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michelle Jagdat, BSc</last_name>
      <phone>416-864-6060</phone>
      <phone_ext>2893</phone_ext>
      <email>jagdatm@smh.ca</email>
    </contact>
    <investigator>
      <last_name>Fil Altomare, MD, FRCSC</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>September 16, 2016</study_first_submitted>
  <study_first_submitted_qc>September 16, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 21, 2016</study_first_posted>
  <last_update_submitted>May 21, 2019</last_update_submitted>
  <last_update_submitted_qc>May 21, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 23, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

